HIVインテグラーゼ鎖転移阻害剤（INSTI）の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024）

• 英文タイトル：Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market 2019 by Company, Regions, Type and Application, Forecast to 2024

• レポートコード：B-GIR08C2782
• 出版社/出版日：GlobalInfoResearch / 2019年8月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、138ページ
• 納品方法：Eメール
• 産業分類：Pharma & Healthcare

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

本調査レポートは、HIVインテグラーゼ鎖転移阻害剤（INSTI）の世界市場について調べ、まとめました。種類別セグメントは、ラルテグラビル、エルビテグラビル配合剤、ドルテグラビル及びその配合剤、ビクテグラビル配合剤、カボテグラビル、その他等、用途別セグメントは、低減化、反射除去、彩度増加、中性濃度等に区分しました。HIVインテグラーゼ鎖転移阻害剤（INSTI）の世界市場概観、企業動向、企業別HIVインテグラーゼ鎖転移阻害剤（INSTI）シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。
・HIVインテグラーゼ鎖転移阻害剤（INSTI）の市場概観
・HIVインテグラーゼ鎖転移阻害剤（INSTI）の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等）
・HIVインテグラーゼ鎖転移阻害剤（INSTI）の企業別販売動向、市場シェア、市場集中度、競争動向
・HIVインテグラーゼ鎖転移阻害剤（INSTI）の世界市場規模
・HIVインテグラーゼ鎖転移阻害剤（INSTI）の北米市場分析（アメリカ、カナダ、メキシコ等）
・HIVインテグラーゼ鎖転移阻害剤（INSTI）のアメリカ市場規模推移
・HIVインテグラーゼ鎖転移阻害剤（INSTI）のカナダ市場規模推移
・HIVインテグラーゼ鎖転移阻害剤（INSTI）のメキシコ市場規模推移
・HIVインテグラーゼ鎖転移阻害剤（INSTI）のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）
・HIVインテグラーゼ鎖転移阻害剤（INSTI）のドイツ市場規模推移
・HIVインテグラーゼ鎖転移阻害剤（INSTI）のイギリス市場規模推移
・HIVインテグラーゼ鎖転移阻害剤（INSTI）のロシア市場規模推移
・HIVインテグラーゼ鎖転移阻害剤（INSTI）のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等）
・HIVインテグラーゼ鎖転移阻害剤（INSTI）の日本市場規模推移
・HIVインテグラーゼ鎖転移阻害剤（INSTI）の中国市場規模推移
・HIVインテグラーゼ鎖転移阻害剤（INSTI）の韓国市場規模推移
・HIVインテグラーゼ鎖転移阻害剤（INSTI）のインド市場規模推移
・HIVインテグラーゼ鎖転移阻害剤（INSTI）の東南アジア市場規模推移
・HIVインテグラーゼ鎖転移阻害剤（INSTI）の南米市場分析（ブラジル、アルゼンチン等）
・HIVインテグラーゼ鎖転移阻害剤（INSTI）の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等）
・HIVインテグラーゼ鎖転移阻害剤（INSTI）の種類別分析/販売量、売上、市場シェア（ラルテグラビル、エルビテグラビル配合剤、ドルテグラビル及びその配合剤、ビクテグラビル配合剤、カボテグラビル、その他）
・HIVインテグラーゼ鎖転移阻害剤（INSTI）の用途別分析/市場規模（低減化、反射除去、彩度増加、中性濃度）
・HIVインテグラーゼ鎖転移阻害剤（INSTI）の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測）
・HIVインテグラーゼ鎖転移阻害剤（INSTI）の販売チャネル・代理店・貿易業者・ディーラー分析

Scope of the Report:
The global HIV Integrase Strand Transfer Inhibitors (INSTI) market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of HIV Integrase Strand Transfer Inhibitors (INSTI).
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the HIV Integrase Strand Transfer Inhibitors (INSTI) market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the HIV Integrase Strand Transfer Inhibitors (INSTI) market by product type and applications/end industries.

Market Segment by Companies, this report covers
Adcock Ingram Limited
Affine Formulations Limited
Aurobindo Pharma
Biocon Limited
Bristol-Myers Squibb
Cipla
Emcure Pharmaceuticals
Flamingo Pharmaceuticals Limited
Gilead Sciences
Hetero Drugs
IPCA Laboratories
Janssen Pharmaceutica (Johnson & Johnson)
LAURUS Labs
Medisist Pharma
Merck
Mylan
Ranbaxy Pharmaceuticals
Shanghai Desano Pharmaceuticals
ViiV Healthcare (GSK)

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Raltegravir
Elvitegravir Combination Drugs
Dolutegravir and Its Combination Drug
Bictegravir Combination Drug
Cabotegravir
Other

Market Segment by Applications, can be divided into
Hospital
Clinic
Drug Center
Other

レポート目次

Table of Contents

1 HIV Integrase Strand Transfer Inhibitors (INSTI) Market Overview
1.1 Product Overview and Scope of HIV Integrase Strand Transfer Inhibitors (INSTI)
1.2 Classification of HIV Integrase Strand Transfer Inhibitors (INSTI) by Types
1.2.1 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Comparison by Types (2019-2024)
1.2.2 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Market Share by Types in 2018
1.2.3 Raltegravir
1.2.4 Elvitegravir Combination Drugs
1.2.5 Dolutegravir and Its Combination Drug
1.2.6 Bictegravir Combination Drug
1.2.7 Cabotegravir
1.2.8 Other
1.3 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market by Application
1.3.1 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Drug Center
1.3.5 Other
1.4 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market by Regions
1.4.1 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) HIV Integrase Strand Transfer Inhibitors (INSTI) Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) HIV Integrase Strand Transfer Inhibitors (INSTI) Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) HIV Integrase Strand Transfer Inhibitors (INSTI) Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) HIV Integrase Strand Transfer Inhibitors (INSTI) Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) HIV Integrase Strand Transfer Inhibitors (INSTI) Status and Prospect (2014-2024)
1.5 Global Market Size of HIV Integrase Strand Transfer Inhibitors (INSTI) (2014-2024)
2 Manufacturers Profiles
2.1 Adcock Ingram Limited
2.1.1 Business Overview
2.1.2 HIV Integrase Strand Transfer Inhibitors (INSTI) Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Adcock Ingram Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, Gross Margin and Market Share (2017-2018)
2.2 Affine Formulations Limited
2.2.1 Business Overview
2.2.2 HIV Integrase Strand Transfer Inhibitors (INSTI) Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Affine Formulations Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, Gross Margin and Market Share (2017-2018)
2.3 Aurobindo Pharma
2.3.1 Business Overview
2.3.2 HIV Integrase Strand Transfer Inhibitors (INSTI) Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Aurobindo Pharma HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, Gross Margin and Market Share (2017-2018)
2.4 Biocon Limited
2.4.1 Business Overview
2.4.2 HIV Integrase Strand Transfer Inhibitors (INSTI) Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Biocon Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, Gross Margin and Market Share (2017-2018)
2.5 Bristol-Myers Squibb
2.5.1 Business Overview
2.5.2 HIV Integrase Strand Transfer Inhibitors (INSTI) Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Bristol-Myers Squibb HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, Gross Margin and Market Share (2017-2018)
2.6 Cipla
2.6.1 Business Overview
2.6.2 HIV Integrase Strand Transfer Inhibitors (INSTI) Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Cipla HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, Gross Margin and Market Share (2017-2018)
2.7 Emcure Pharmaceuticals
2.7.1 Business Overview
2.7.2 HIV Integrase Strand Transfer Inhibitors (INSTI) Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Emcure Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, Gross Margin and Market Share (2017-2018)
2.8 Flamingo Pharmaceuticals Limited
2.8.1 Business Overview
2.8.2 HIV Integrase Strand Transfer Inhibitors (INSTI) Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Flamingo Pharmaceuticals Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, Gross Margin and Market Share (2017-2018)
2.9 Gilead Sciences
2.9.1 Business Overview
2.9.2 HIV Integrase Strand Transfer Inhibitors (INSTI) Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Gilead Sciences HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, Gross Margin and Market Share (2017-2018)
2.10 Hetero Drugs
2.10.1 Business Overview
2.10.2 HIV Integrase Strand Transfer Inhibitors (INSTI) Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Hetero Drugs HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, Gross Margin and Market Share (2017-2018)
2.11 IPCA Laboratories
2.11.1 Business Overview
2.11.2 HIV Integrase Strand Transfer Inhibitors (INSTI) Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 IPCA Laboratories HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, Gross Margin and Market Share (2017-2018)
2.12 Janssen Pharmaceutica (Johnson & Johnson)
2.12.1 Business Overview
2.12.2 HIV Integrase Strand Transfer Inhibitors (INSTI) Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Janssen Pharmaceutica (Johnson & Johnson) HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, Gross Margin and Market Share (2017-2018)
2.13 LAURUS Labs
2.13.1 Business Overview
2.13.2 HIV Integrase Strand Transfer Inhibitors (INSTI) Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 LAURUS Labs HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, Gross Margin and Market Share (2017-2018)
2.14 Medisist Pharma
2.14.1 Business Overview
2.14.2 HIV Integrase Strand Transfer Inhibitors (INSTI) Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Medisist Pharma HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, Gross Margin and Market Share (2017-2018)
2.15 Merck
2.15.1 Business Overview
2.15.2 HIV Integrase Strand Transfer Inhibitors (INSTI) Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Merck HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, Gross Margin and Market Share (2017-2018)
2.16 Mylan
2.16.1 Business Overview
2.16.2 HIV Integrase Strand Transfer Inhibitors (INSTI) Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Mylan HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, Gross Margin and Market Share (2017-2018)
2.17 Ranbaxy Pharmaceuticals
2.17.1 Business Overview
2.17.2 HIV Integrase Strand Transfer Inhibitors (INSTI) Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 Ranbaxy Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, Gross Margin and Market Share (2017-2018)
2.18 Shanghai Desano Pharmaceuticals
2.18.1 Business Overview
2.18.2 HIV Integrase Strand Transfer Inhibitors (INSTI) Type and Applications
2.18.2.1 Product A
2.18.2.2 Product B
2.18.3 Shanghai Desano Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, Gross Margin and Market Share (2017-2018)
2.19 ViiV Healthcare (GSK)
2.19.1 Business Overview
2.19.2 HIV Integrase Strand Transfer Inhibitors (INSTI) Type and Applications
2.19.2.1 Product A
2.19.2.2 Product B
2.19.3 ViiV Healthcare (GSK) HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, Gross Margin and Market Share (2017-2018)
3 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Competition, by Players
3.1 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 HIV Integrase Strand Transfer Inhibitors (INSTI) Players Market Share
3.2.2 Top 10 HIV Integrase Strand Transfer Inhibitors (INSTI) Players Market Share
3.3 Market Competition Trend
4 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Regions
4.1 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue and Market Share by Regions
4.2 North America HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue and Growth Rate (2014-2019)
4.3 Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue and Growth Rate (2014-2019)
4.5 South America HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue and Growth Rate (2014-2019)
5 North America HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue by Countries
5.1 North America HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue by Countries (2014-2019)
5.2 USA HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue and Growth Rate (2014-2019)
5.3 Canada HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue and Growth Rate (2014-2019)
5.4 Mexico HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue and Growth Rate (2014-2019)
6 Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue by Countries
6.1 Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue by Countries (2014-2019)
6.2 Germany HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue and Growth Rate (2014-2019)
6.3 UK HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue and Growth Rate (2014-2019)
6.4 France HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue and Growth Rate (2014-2019)
6.5 Russia HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue and Growth Rate (2014-2019)
6.6 Italy HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue and Growth Rate (2014-2019)
7 Asia-Pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue by Countries
7.1 Asia-Pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue by Countries (2014-2019)
7.2 China HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue and Growth Rate (2014-2019)
7.3 Japan HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue and Growth Rate (2014-2019)
7.4 Korea HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue and Growth Rate (2014-2019)
7.5 India HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue and Growth Rate (2014-2019)
8 South America HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue by Countries
8.1 South America HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue by Countries (2014-2019)
8.2 Brazil HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue and Growth Rate (2014-2019)
8.3 Argentina HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue and Growth Rate (2014-2019)
8.4 Colombia HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue HIV Integrase Strand Transfer Inhibitors (INSTI) by Countries
9.1 Middle East and Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue by Countries (2014-2019)
9.2 Saudi Arabia HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue and Growth Rate (2014-2019)
9.3 UAE HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue and Growth Rate (2014-2019)
9.4 Egypt HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue and Growth Rate (2014-2019)
9.5 Nigeria HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue and Growth Rate (2014-2019)
9.6 South Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue and Growth Rate (2014-2019)
10 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Segment by Type
10.1 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue and Market Share by Type (2014-2019)
10.2 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Forecast by Type (2019-2024)
10.3 Raltegravir Revenue Growth Rate (2014-2024)
10.4 Elvitegravir Combination Drugs Revenue Growth Rate (2014-2024)
10.5 Dolutegravir and Its Combination Drug Revenue Growth Rate (2014-2024)
10.6 Bictegravir Combination Drug Revenue Growth Rate (2014-2024)
10.7 Cabotegravir Revenue Growth Rate (2014-2024)
10.8 Other Revenue Growth Rate (2014-2024)
11 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Segment by Application
11.1 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Market Share by Application (2014-2019)
11.2 HIV Integrase Strand Transfer Inhibitors (INSTI) Market Forecast by Application (2019-2024)
11.3 Hospital Revenue Growth (2014-2019)
11.4 Clinic Revenue Growth (2014-2019)
11.5 Drug Center Revenue Growth (2014-2019)
11.6 Other Revenue Growth (2014-2019)
12 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Forecast (2019-2024)
12.1 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Forecast (2019-2024)
12.2 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Forecast by Regions (2019-2024)
12.3 North America HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Market Forecast (2019-2024)
12.4 Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Market Forecast (2019-2024)
12.6 South America HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source

List of Tables and Figures

Figure HIV Integrase Strand Transfer Inhibitors (INSTI) Picture
Table Product Specifications of HIV Integrase Strand Transfer Inhibitors (INSTI)
Table Global HIV Integrase Strand Transfer Inhibitors (INSTI) and Revenue (Million USD) Market Split by Product Type
Figure Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Market Share by Types in 2018
Figure Raltegravir Picture
Figure Elvitegravir Combination Drugs Picture
Figure Dolutegravir and Its Combination Drug Picture
Figure Bictegravir Combination Drug Picture
Figure Cabotegravir Picture
Figure Other Picture
Table Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue (Million USD) by Application (2014-2024)
Figure HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Market Share by Applications in 2018
Figure Hospital Picture
Figure Clinic Picture
Figure Drug Center Picture
Figure Other Picture
Table Global Market HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue (Million USD) and Growth Rate (2014-2024)
Table Adcock Ingram Limited Basic Information, Manufacturing Base and Competitors
Table Adcock Ingram Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Type and Applications
Table Adcock Ingram Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, Gross Margin and Market Share (2017-2018)
Table Affine Formulations Limited Basic Information, Manufacturing Base and Competitors
Table Affine Formulations Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Type and Applications
Table Affine Formulations Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, Gross Margin and Market Share (2017-2018)
Table Aurobindo Pharma Basic Information, Manufacturing Base and Competitors
Table Aurobindo Pharma HIV Integrase Strand Transfer Inhibitors (INSTI) Type and Applications
Table Aurobindo Pharma HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, Gross Margin and Market Share (2017-2018)
Table Biocon Limited Basic Information, Manufacturing Base and Competitors
Table Biocon Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Type and Applications
Table Biocon Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, Gross Margin and Market Share (2017-2018)
Table Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table Bristol-Myers Squibb HIV Integrase Strand Transfer Inhibitors (INSTI) Type and Applications
Table Bristol-Myers Squibb HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, Gross Margin and Market Share (2017-2018)
Table Cipla Basic Information, Manufacturing Base and Competitors
Table Cipla HIV Integrase Strand Transfer Inhibitors (INSTI) Type and Applications
Table Cipla HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, Gross Margin and Market Share (2017-2018)
Table Emcure Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Emcure Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Type and Applications
Table Emcure Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, Gross Margin and Market Share (2017-2018)
Table Flamingo Pharmaceuticals Limited Basic Information, Manufacturing Base and Competitors
Table Flamingo Pharmaceuticals Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Type and Applications
Table Flamingo Pharmaceuticals Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, Gross Margin and Market Share (2017-2018)
Table Gilead Sciences Basic Information, Manufacturing Base and Competitors
Table Gilead Sciences HIV Integrase Strand Transfer Inhibitors (INSTI) Type and Applications
Table Gilead Sciences HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, Gross Margin and Market Share (2017-2018)
Table Hetero Drugs Basic Information, Manufacturing Base and Competitors
Table Hetero Drugs HIV Integrase Strand Transfer Inhibitors (INSTI) Type and Applications
Table Hetero Drugs HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, Gross Margin and Market Share (2017-2018)
Table IPCA Laboratories Basic Information, Manufacturing Base and Competitors
Table IPCA Laboratories HIV Integrase Strand Transfer Inhibitors (INSTI) Type and Applications
Table IPCA Laboratories HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, Gross Margin and Market Share (2017-2018)
Table Janssen Pharmaceutica (Johnson & Johnson) Basic Information, Manufacturing Base and Competitors
Table Janssen Pharmaceutica (Johnson & Johnson) HIV Integrase Strand Transfer Inhibitors (INSTI) Type and Applications
Table Janssen Pharmaceutica (Johnson & Johnson) HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, Gross Margin and Market Share (2017-2018)
Table LAURUS Labs Basic Information, Manufacturing Base and Competitors
Table LAURUS Labs HIV Integrase Strand Transfer Inhibitors (INSTI) Type and Applications
Table LAURUS Labs HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, Gross Margin and Market Share (2017-2018)
Table Medisist Pharma Basic Information, Manufacturing Base and Competitors
Table Medisist Pharma HIV Integrase Strand Transfer Inhibitors (INSTI) Type and Applications
Table Medisist Pharma HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, Gross Margin and Market Share (2017-2018)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck HIV Integrase Strand Transfer Inhibitors (INSTI) Type and Applications
Table Merck HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, Gross Margin and Market Share (2017-2018)
Table Mylan Basic Information, Manufacturing Base and Competitors
Table Mylan HIV Integrase Strand Transfer Inhibitors (INSTI) Type and Applications
Table Mylan HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, Gross Margin and Market Share (2017-2018)
Table Ranbaxy Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Ranbaxy Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Type and Applications
Table Ranbaxy Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, Gross Margin and Market Share (2017-2018)
Table Shanghai Desano Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Shanghai Desano Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Type and Applications
Table Shanghai Desano Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, Gross Margin and Market Share (2017-2018)
Table ViiV Healthcare (GSK) Basic Information, Manufacturing Base and Competitors
Table ViiV Healthcare (GSK) HIV Integrase Strand Transfer Inhibitors (INSTI) Type and Applications
Table ViiV Healthcare (GSK) HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, Gross Margin and Market Share (2017-2018)
Table Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue (Million USD) by Players (2014-2019)
Table Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Share by Players (2014-2019)
Figure Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Share by Players in 2017
Figure Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Share by Players in 2018
Figure Global Top 5 Players HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Market Share in 2018
Figure Global Top 10 Players HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Market Share in 2018
Figure Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue (Million USD) by Regions (2014-2019)
Table Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Market Share by Regions (2014-2019)
Figure Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Market Share by Regions (2014-2019)
Figure Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Market Share by Regions in 2018
Figure North America HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue and Growth Rate (2014-2019)
Figure Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue and Growth Rate (2014-2019)
Figure South America HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue and Growth Rate (2014-2019)
Table North America HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue by Countries (2014-2019)
Table North America HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Market Share by Countries (2014-2019)
Figure North America HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Market Share by Countries (2014-2019)
Figure North America HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Market Share by Countries in 2018
Figure USA HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue and Growth Rate (2014-2019)
Figure Canada HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue and Growth Rate (2014-2019)
Figure Mexico HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue and Growth Rate (2014-2019)
Table Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue (Million USD) by Countries (2014-2019)
Figure Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Market Share by Countries (2014-2019)
Figure Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Market Share by Countries in 2018
Figure Germany HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue and Growth Rate (2014-2019)
Figure UK HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue and Growth Rate (2014-2019)
Figure France HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue and Growth Rate (2014-2019)
Figure Russia HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue and Growth Rate (2014-2019)
Figure Italy HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue and Growth Rate (2014-2019)
Table Asia-Pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Market Share by Countries in 2018
Figure China HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue and Growth Rate (2014-2019)
Figure Japan HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue and Growth Rate (2014-2019)
Figure Korea HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue and Growth Rate (2014-2019)
Figure India HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue and Growth Rate (2014-2019)
Figure Southeast Asia HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue and Growth Rate (2014-2019)
Table South America HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue by Countries (2014-2019)
Table South America HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Market Share by Countries (2014-2019)
Figure South America HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Market Share by Countries (2014-2019)
Figure South America HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Market Share by Countries in 2018
Figure Brazil HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue and Growth Rate (2014-2019)
Figure Argentina HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue and Growth Rate (2014-2019)
Figure Colombia HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue and Growth Rate (2014-2019)
Table Middle East and Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Market Share by Countries in 2018
Figure Saudi Arabia HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue and Growth Rate (2014-2019)
Figure UAE HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue and Growth Rate (2014-2019)
Figure Egypt HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue and Growth Rate (2014-2019)
Figure Nigeria HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue and Growth Rate (2014-2019)
Figure South Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue and Growth Rate (2014-2019)
Table Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue (Million USD) by Type (2014-2019)
Table Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Share by Type (2014-2019)
Figure Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Share by Type (2014-2019)
Figure Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Share by Type in 2018
Table Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Forecast by Type (2019-2024)
Figure Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share Forecast by Type (2019-2024)
Figure Global Raltegravir Revenue Growth Rate (2014-2019)
Figure Global Elvitegravir Combination Drugs Revenue Growth Rate (2014-2019)
Figure Global Dolutegravir and Its Combination Drug Revenue Growth Rate (2014-2019)
Figure Global Bictegravir Combination Drug Revenue Growth Rate (2014-2019)
Figure Global Cabotegravir Revenue Growth Rate (2014-2019)
Figure Global Other Revenue Growth Rate (2014-2019)
Table Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue by Application (2014-2019)
Table Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Share by Application (2014-2019)
Figure Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Share by Application (2014-2019)
Figure Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Share by Application in 2018
Table Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Forecast by Application (2019-2024)
Figure Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Share Forecast by Application (2019-2024)
Figure Global Hospital Revenue Growth Rate (2014-2019)
Figure Global Clinic Revenue Growth Rate (2014-2019)
Figure Global Drug Center Revenue Growth Rate (2014-2019)
Figure Global Other Revenue Growth Rate (2014-2019)
Figure Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Market Share Forecast by Regions (2019-2024)
Figure North America HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Market Forecast (2019-2024)
Figure Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Market Forecast (2019-2024)
Figure Asia-Pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Market Forecast (2019-2024)
Figure South America HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Market Forecast (2019-2024)
Figure Middle East and Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Market Forecast (2019-2024)

Global Low Dosage Hydrate Inhibitors (LDHI) Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
B-GIR08C3467 2019年8月 116Pages
本調査レポートは、低用量ハイドレート阻害剤(LDHI)の世界市場について調べ、まとめました。種類別セグメントは、抗凝集（AA）防止剤、キネティックハイドレート防止剤（KHI）、その他等、用途別セグメントは、陸上、海洋等に区分しました。低用量ハイドレート阻害剤(LDHI)の世界市場概観、企業動向、企業...

クローズドシステム転送装置（CSTD）の世界市場予測 2019年：メーカー別、地域別、種類・用途別（～2024）

Global Closed System Transfer Device (CSTD) Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
B-GIR08C1287 2019年8月 115Pages
本調査レポートは、クローズドシステム転送装置（CSTD）の世界市場について調べ、まとめました。種類別セグメントは、閉鎖型バイアルアクセス装置、クローズドシリンジ安全装置、クローズドバッグ/ラインアクセス装置等、用途別セグメントは、電線、電子部品、その他等に区分しました。クローズドシステム転送装置（C...

プレストレスト鋼ストランドの世界市場予測 2019年：メーカー別、地域別、種類・用途別（～2024）

Global Prestressed Steel Strand Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
B-GIR08C4712 2019年8月 135Pages
本調査レポートは、プレストレスト鋼ストランドの世界市場について調べ、まとめました。種類別セグメントは、ベアPCストランド、グレーズフルPCストランド、ワックスフルPCストランドなど等、用途別セグメントは、橋、建物、原子炉、その他等に区分しました。プレストレスト鋼ストランドの世界市場概観、企業動向、企...

NSCLC用標的薬物MEK阻害剤の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024）

Global Targeted Drug MEK Inhibitors for NSCLC Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR08C5672 2019年7月 109Pages
本調査レポートは、NSCLC用標的薬物MEK阻害剤の世界市場について調べ、まとめました。種類別セグメントは、トラメチニブ、その他等、用途別セグメントは、等に区分しました。NSCLC用標的薬物MEK阻害剤の世界市場概観、企業動向、企業別NSCLC用標的薬物MEK阻害剤シェア、市場規模推移、市場規模予測...

NSCLC用標的薬剤VEGFR2阻害剤の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024）

Global Targeted Drug VEGFR2 Inhibitors for NSCLC Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR08C5675 2019年7月 107Pages
本調査レポートは、NSCLC用標的薬剤VEGFR2阻害剤の世界市場について調べ、まとめました。種類別セグメントは、ラムシルマブ、その他等、用途別セグメントは、等に区分しました。NSCLC用標的薬剤VEGFR2阻害剤の世界市場概観、企業動向、企業別NSCLC用標的薬剤VEGFR2阻害剤シェア、市場規模...

乳がんPARP阻害剤の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024）

Global PARP Inhibitors for Breast Cancer Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR08C4300 2019年8月 104Pages
本調査レポートは、乳がんPARP阻害剤の世界市場について調べ、まとめました。種類別セグメントは、オラパリブ、タラゾパリブ等、用途別セグメントは、携帯電話アクセサリー店、3C小売店、個人等に区分しました。乳がんPARP阻害剤の世界市場概観、企業動向、企業別乳がんPARP阻害剤シェア、市場規模推移、市場...

多発性骨髄腫プロテアソーム阻害薬の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024）

Global Proteasome Inhibitors for Multiple Myeloma Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR08C4758 2019年8月 109Pages
本調査レポートは、多発性骨髄腫プロテアソーム阻害薬の世界市場について調べ、まとめました。種類別セグメントは、ボルテゾミブ、カルフィルゾミブ、イキサゾミブ、その他等、用途別セグメントは、ものづくり、ヘルスケア、輸送、情報通信、エネルギー・ユーティリティ、その他等に区分しました。多発性骨髄腫プロテアソー...

NSCLC用標的薬BRAF阻害剤の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024）

Global Targeted Drug BRAF Inhibitors for NSCLC Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR08C5669 2019年7月 100Pages
本調査レポートは、NSCLC用標的薬BRAF阻害剤の世界市場について調べ、まとめました。種類別セグメントは、ダブラフェニブ、トラメチニブ、リフィラフェニブ、その他等、用途別セグメントは、等に区分しました。NSCLC用標的薬BRAF阻害剤の世界市場概観、企業動向、企業別NSCLC用標的薬BRAF阻害剤...

乳がんCDK4 / 6阻害剤の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024）

Global CDK4/6 Inhibitors for Breast Cancer Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR08C1129 2019年7月 116Pages
本調査レポートは、乳がんCDK4 / 6阻害剤の世界市場について調べ、まとめました。種類別セグメントは、等、用途別セグメントは、子供、大人等に区分しました。乳がんCDK4 / 6阻害剤の世界市場概観、企業動向、企業別乳がんCDK4 / 6阻害剤シェア、市場規模推移、市場規模予測（2019年-2024...

NSCLC用標的薬物HER2阻害剤の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024）

Global Targeted Drug HER2 Inhibitors for NSCLC Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR08C5671 2019年7月 104Pages
本調査レポートは、NSCLC用標的薬物HER2阻害剤の世界市場について調べ、まとめました。種類別セグメントは、アファチニブ、トラスツズマブ、その他等、用途別セグメントは、等に区分しました。NSCLC用標的薬物HER2阻害剤の世界市場概観、企業動向、企業別NSCLC用標的薬物HER2阻害剤シェア、市場...

世界のストランドペレタイザー市場2019 The global Strand Pelletizers market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report studies the global Strand Pelletizers market status and forecast, categorizes the global Strand Pelletizers market size (value & vo…
包装用配向性ストランドボード市場：世界及び中国の市場分析・予測（～2024年） Oriented Strand Board for Packaging Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Oriented Strand Board for Packaging industry with a focus on the Chinese market. The report provides key statistics on the market status of th…
家具用配向性ストランドボード市場：世界及び中国市場分析・予測（～2024年） Oriented strand board for Furniture Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Oriented strand board for Furniture industry with a focus on the Chinese market. The report provides key statistics on the market status of th…
世界のプレストレストコンクリート鋼ストランド市場2019 The global Prestressed Concrete Steel Strand market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report studies the global Prestressed Concrete Steel Strand market status and forecast, categorizes the global Prestressed …
ダブルストランドローラーチェーンドライブ市場：世界及び中国市場分析・予測（～2024年） Double Strand Roller Chain Drives Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Double Strand Roller Chain Drives industry with a focus on the Chinese market. The report provides key statistics on the market status of the Do…